4//SEC Filing
Oliviero James F III 4
Accession 0001104659-25-011656
CIK 0001651407other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 9:00 PM ET
Size
7.7 KB
Accession
0001104659-25-011656
Insider Transaction Report
Form 4
Oliviero James F III
DirectorCEO, President and Director
Transactions
- Sale
COMMON STOCK
2025-02-07$3.41/sh−9,233$31,485→ 3,785,350 total - Sale
COMMON STOCK
2025-02-10$3.15/sh−10,331$32,543→ 3,775,019 total
Footnotes (4)
- [F1]In connection with the vesting of restricted shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- [F2]Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $3.40 to $3.41. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes shares of restricted common stock, which vest over various time periods.
- [F4]Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $3.14 to $3.16. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Checkpoint Therapeutics, Inc.
CIK 0001651407
Entity typeother
Related Parties
1- filerCIK 0001434718
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 9:00 PM ET
- Size
- 7.7 KB